Whole Body MRI Imaging in Multiple Myeloma at 3 Tesla MRI : Added Value of Diffusion Weighted Imaging
Conditions
Multiple Myeloma
Conditions: official terms
Multiple Myeloma - Neoplasms, Plasma Cell
Conditions: Keywords
Whole body MRI, Multiple myeloma, Diffusion Weighted MRI, Whole body scan
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Case-Only, Time Perspective: Prospective
Overall Status
Recruiting
Summary
Whole body MRI with diffusion weighted imaging is a useful imaging tool

- staging and diagnosis

- therapy monitoring All patients will be scanned before and during treatment. The findings on diffusion weighted imaging will be correlated to the golden standard (computer tomography and MRI (T1 and STIR)).
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 25 Years
Gender: Both
Criteria: Inclusion Criteria:

- Patients with clinical and laboratory findings, highly suggestive for multiple myeloma.

Exclusion Criteria:

- All patients who are not allowed to be scanned on MRI (Pacemaker, implants ed.)
Location
University Hospitals Leuven
Leuven, Belgium
Status: Recruiting
Contact: Steven Pans, MD - 3216340505 - steven.pans@uzleuven.be
Start Date
September 2008
Completion Date
September 2014
Sponsors
Universitaire Ziekenhuizen Leuven
Source
Universitaire Ziekenhuizen Leuven
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page